Details for New Drug Application (NDA): 215856
✉ Email this page to a colleague
The generic ingredient in FUROSEMIDE is furosemide. There are twenty-two drug master file entries for this compound. Fifty-seven suppliers are listed for this compound. Additional details are available on the furosemide profile page.
Summary for 215856
Tradename: | FUROSEMIDE |
Applicant: | Saba Ilac Sanayive |
Ingredient: | furosemide |
Patents: | 0 |
Pharmacology for NDA: 215856
Physiological Effect | Increased Diuresis at Loop of Henle |
Medical Subject Heading (MeSH) Categories for 215856
Suppliers and Packaging for NDA: 215856
Tradename | Generic Name | Dosage | NDA | Application Type | Supplier | National Drug Code | Package Code | Package |
---|---|---|---|---|---|---|---|---|
FUROSEMIDE | furosemide | INJECTABLE;INJECTION | 215856 | ANDA | Devatis Inc. | 73043-022 | 73043-022-01 | 25 VIAL, GLASS in 1 BOX (73043-022-01) / 2 mL in 1 VIAL, GLASS |
FUROSEMIDE | furosemide | INJECTABLE;INJECTION | 215856 | ANDA | Devatis Inc. | 73043-023 | 73043-023-01 | 25 VIAL, GLASS in 1 BOX (73043-023-01) / 4 mL in 1 VIAL, GLASS |
Profile for product number 001
Active Rx/OTC/Discontinued: | RX | Dosage: | INJECTABLE;INJECTION | Strength | 10MG/ML | ||||
Approval Date: | Apr 2, 2024 | TE: | AP | RLD: | No |
Complete Access Available with Subscription